Stress hyperglycemia: An essential survival response!

Critical Care

Volumn 17, Issue 2, 2013, Pages

  Marik, Paul E ^a   Bellomo, Rinaldo ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Australian and New Zealand Intensive Care Research Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ARTICLE; CRITICAL ILLNESS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTENSIVE CARE UNIT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STRESS; STRESS HYPERGLYCEMIA; SURVIVAL; ANIMAL; BLOOD; GLYCEMIC INDEX; INTENSIVE CARE; METABOLISM; MORTALITY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; TRENDS;

ANIMALS; BLOOD GLUCOSE; CRITICAL CARE; CRITICAL ILLNESS; GLYCEMIC INDEX; HUMANS; HYPERGLYCEMIA; STRESS, PHYSIOLOGICAL; SURVIVAL;

EID: 84874718741     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12514     Document Type: Article

References (46)

1. Bernard C. Lecons sur les Phenomenes de la Vie Communs aux Animaux et aux Vegetaux 1878, Paris, France: JB Bailliere et fils.
2. Badawi O, Waite MD, Fuhrman SA, Zuckerman IH. Association between intensive care unit-acquired dysglycemia and in-hospital mortality. Crit Care Med 2012, 40:3180-3188. 10.1097/CCM.0b013e3182656ae5, 22971590.
3. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002, 59:669-674. 10.1212/WNL.59.5.669, 12221155.
4. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355:773-778. 10.1016/S0140-6736(99)08415-9, 10711923.
5. Dungan K, Braithwaite SS, Preiser JC. Stress hyperglycemia. Lancet 2009, 373:1798-1807. 10.1016/S0140-6736(09)60553-5, 3144755, 19465235.
6. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008, 300:933-944. 10.1001/jama.300.8.933, 18728267.
7. Kansagara D, Fu R, Freeman M, Wolf F, Helfand M. Intensive insulin therapy in hospitalized patients: A systematic review. Ann Intern Med 2011, 154:268-282.
8. Marik PE, Preiser JC. Towards understanding tight glycemic control in the ICU: A systemic review and meta-analysis. Chest 2010, 137:544-551. 10.1378/chest.09-1737, 20018803.
9. Intensive versus conventional glucose control in critically ill patients: The NICE-Sugar Study Investigators. N Engl J Med 2009, 360:1283-1297.
10. Green JP, Berger T, Garg N, Horeczko T, Suarez A, Radeos MS, Hagar Y, Panacek EA. Hyperlactemia affects the association of hyperglycemia with mortality in nondiabetic adults with sepsis. Acad Emerg Med 2012, 19:1268-1275. 10.1111/acem.12015, 23167858.
11. Tiruvoipati R, Chiezey B, Lewis D, Ong K, Villanueva E, Haji K, Botha J. Stress hyperglycemia may not be harmful in critically ill patients with sepsis. J Crit Care 2012, 27:153-158. 10.1016/j.jcrc.2011.06.011, 21855283.
12. Marik PE. Critical illness related corticoseroid insufficiency. Chest 2009, 135:181-193. 10.1378/chest.08-1149, 19136406.
13. Chernow B, Rainey TR, Lake CR. Endogenous and exogenous catecholamines in critical care medicine. Crit Care Med 1982, 10:409-416. 10.1097/00003246-198206000-00019, 7042207.
14. Jernas M, Olsson B, Sjoholm K, Sjogren A, Rudemo M, Nellgard B, Carlsson LM, Sjostrom CD. Changes in adipose tissue gene expression and plasma levels of adipokines and acute-phase proteins in patients with critical illness. Metabolism 2009, 58:102-108. 10.1016/j.metabol.2008.08.012, 19059537.
15. Hart BB, Stanford GG, Ziegler MG, Lake CR, Chernow B. Catecholamines: study of interspecies variation. Crit Care Med 1989, 17:1203-1218. 10.1097/00003246-198911000-00021, 2676350.
16. Marik PE, Levitov A. The "koala stress syndrome" and adrenal responsiveness in the critically ill. Intensive Care Med 2010, 36:1805-1806. 10.1007/s00134-010-1974-6, 20665003.
17. Soeters MR, Soeters PB. The evolutionary benefit of insulin resistance. Clin Nutr 2012, 31:1002-1007. 10.1016/j.clnu.2012.05.011, 22682085.
18. Barreto RE, Volpato GL. Stress responses of the fish Nile tilapia subjected to electroshock and social stressors. Braz J Med Biol Res 2006, 39:1605-1612. 10.1590/S0100-879X2006001200012, 17160270.
19. McNamara JJ, Mills D, Aaby GV. Effect of hypertonic glucose on hemorrhagic shock in rabbits. Ann Thorac Surg 1970, 9:116-121. 10.1016/S0003-4975(10)65784-0, 5410974.
20. Shepherd PR, Kahn BB. Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. N Engl J Med 1999, 341:248-257. 10.1056/NEJM199907223410406, 10413738.
21. Gamelli RL, Liu H, He LK, Hofmann CA. Alterations of glucose transporter mRNA and protein levels in brain following thermal injury and sepsis in mice. Shock 1994, 1:395-400. 10.1097/00024382-199406000-00001, 7735967.
22. Maratou E, Dimitriadis G, Kollias A, Boutati E, Lambadiari V, Mitrou P, Raptis SA. Glucose transporter expression on the plasma membrane of resting and activated white blood cells. Eur J Clin Invest 2007, 37:282-290. 10.1111/j.1365-2362.2007.01786.x, 17373964.
23. Losser MR, Damoisel C, Payen D. Bench-to-bedside review: Glucose and stress conditions in the intensive care unit. Crit Care 2010, 14:231. 10.1186/cc9100, 2945096, 20727232.
24. Malfitano C, Alba Loureiro TC, Rodrigues B, Sirvente R, Salemi VM, Rabechi NB, Lacchini S, Curi R, Irigoyen MC. Hyperglycaemia protects the heart after myocardial infarction: aspects of programmed cell survival and cell death. Eur J Heart Fail 2010, 12:659-667. 10.1093/eurjhf/hfq053, 20406798.
25. Ma G, Al-Shabrawey M, Johnson JA, Datar R, Tawfik HE, Guo D, Caldwell RB, Caldwell RW. Protection against myocardial ischemia/reperfusion injury by short-term diabetes: enhancement of VEGF formation, capillary density, and activation of cell survival signaling. Naunyn-Schmiedebergs Arch Pharmacol 2006, 373:415-427. 10.1007/s00210-006-0102-1, 16955284.
26. Lang CH, Dobrescu C. Gram-negative infection increases noninsulin-mediated glucose disposal. Endocrinology 1991, 128:645-653. 10.1210/endo-128-2-645, 1989854.
27. Meszaros K, Lang CH, Bagby GJ, Spitzer JJ. In vivo glucose utilization by individual tissues during nonlethal hypermetabolic sepsis. FASEB J 1988, 2:3083-3086.
28. Oddo M, Schmidt M, Carrera E, Badjatia N, Connolly ES, Presciutti M, Ostapkovich ND, Levine JM, Le Roux P, Mayer SA. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: A microdialysis study. Crit Care Med 2008, 36:3233-3238. 10.1097/CCM.0b013e31818f4026, 18936695.
29. Vespa P, McArthur DL, Stein N, Huang SC, Shao W, Filippou M, Etchepare M, Glenn T, Hovda DA. Tight glycemic control increases metabolic distress in traumatic brain injury: a randomized controlled within-subjects trial. Crit Care Med 2012, 40:1923-1929. 10.1097/CCM.0b013e31824e0fcc, 22610193.
30. Duning T, van D, Dickmann A, Volkert T, Wempe C, Reinholz J, Lohmann H, Freise H, Ellger B. Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction. Diabetes Care 2010, 33:639-644. 10.2337/dc09-1740, 2827523, 20032274.
31. Park S, Kim DG, Suh GY, Kang JG, Ju YS, Lee YJ, Park JY, Lee SW, Jung KS. Mild hypoglycemia is independently associated with increased risk of mortality in patients with sepsis: a three year retrospective observational study. Crit Care 2012, 16:R189. 10.1186/cc11674, 23062226.
32. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012, 367:1108-1118.
33. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625. 10.2337/diabetes.54.6.1615, 15919781.
34. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B. Myocardial cell death in human diabetes. Circ Res 2000, 87:1123-1132. 10.1161/01.RES.87.12.1123, 11110769.
35. Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P, Kajstura J. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 2001, 50:2363-2375. 10.2337/diabetes.50.10.2363, 11574421.
36. Xu G, Takashi E, Kudo M, Ishiwata T, Naito Z. Contradictory effects of short-and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway. Exp Mol Pathol 2004, 76:57-65. 10.1016/j.yexmp.2003.08.003, 14738870.
37. Vanhorebeek I, Ellger B, De VR, Boussemaere M, Debaveye Y, Perre SV, Rabbani N, Thornalley PJ, van den Berghe G, Vanhorebeek I, Ellger B, De Vos R, Boussemaere M, Debaveye Y, Perre SV, Rabbani N, Thornalley PJ, Van den Berghe G. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness. Crit Care Med 2009, 37:1355-1364. 10.1097/CCM.0b013e31819cec17, 19242345.
38. Gunst J, Derese I, Aertgeerts A, Ververs EJ, Wauters A, van den Berghe G, Vanhorebeek I. Insufficient autophagy contributes to mitochondrial dysfunction, organ failure, and adverse outcome in an animal model of critical illness. Crit Care Med 2013, 41:182-194. 10.1097/CCM.0b013e3182676657, 23222264.
39. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345:1359-1367. 10.1056/NEJMoa011300, 11794168.
40. Heyland DK, MacDonald S, Keefe L, Drover JW. Total parenteral nutrition in the critically ill patient: a meta-analysis. JAMA 1998, 280:2013-2019. 10.1001/jama.280.23.2013, 9863853.
41. van der Voort PH, Feenstra RA, Bakker AJ, Heide L, Boerma EC, der H. Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients. Clin Endocrinol (Oxf) 2006, 64:141-145. 10.1111/j.1365-2265.2006.02437.x, 16430711.
42. Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, van Cromphaut S, Ingels C. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011, 365:506-517. 10.1056/NEJMoa1102662, 21714640.
43. Macintyre EJ, Majumdar SR, Gamble JM, Minhas-Sandhu JK, Marrie TJ, Eurich DT. Stress hyperglycemia and newly diagnosed diabetes in 2124 patients hospitalized with pneumonia. Am J Med 2012, 125:1036-1023.
44. Bellomo R, Egi M. What is a NICE-SUGAR for patients in the intensive care unit?. Mayo Clin Proc 2009, 84:400-402. 2676121, 19411435.
45. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, Seley JJ, van den Berghe G. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2012, 97:16-38. 10.1210/jc.2011-2098, 22223765.
46. Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite SS, Deutschman C, Freire AX, Greehan D, Kohl B, Nasraway SA, Rigby M, Sands K, Schallom L, Taylor B, Umpierrez G, Mazuski J, Schunemann H. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012, 40:3251-3276. 10.1097/CCM.0b013e3182653269, 23164767.